Correction: Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models

• This correction addresses an artifact in Fig. 6H of the original article, ensuring accurate representation of data. • The corrected image clarifies the effects of sNEP-NSC transplantation on amyloid pathology in a second transgenic AD model. • The study underscores the potential of genetically modified neural stem cells expressing neprilysin as a therapeutic strategy for Alzheimer's disease. • The correction maintains the integrity of the original findings, which showed reduced plaque pathology and synaptotoxicity.